James M. Frincke
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology
- Oncology top 10%
- Organic Chemistry top 10%
- Immunology
- Co-authors
- D. John FaulknerGary S. DavidRichard M. BartholomewChristopher L. ReadingClarence AhlemDwight R. StickneyPhillip L. HaganSamuel E. Halpern
- Topics
- Radiopharmaceutical Chemistry and Applications (20 papers)Monoclonal and Polyclonal Antibodies Research (17 papers)Estrogen and related hormone effects (14 papers)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
James M. Frincke
73 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 119
- Radiology, Nuclear Medicine and Imaging 1.1k
- Molecular Biology 577
- Oncology 437
- Organic Chemistry 234
- Immunology 204
Countries citing papers authored by James M. Frincke
This map shows the geographic impact of James M. Frincke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Frincke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Frincke more than expected).
Fields of papers citing papers by James M. Frincke
This network shows the impact of papers produced by James M. Frincke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Frincke. The network helps show where James M. Frincke may publish in the future.
Co-authorship network of co-authors of James M. Frincke
This figure shows the co-authorship network connecting the top 25 collaborators of James M. Frincke. A scholar is included among the top collaborators of James M. Frincke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Frincke. James M. Frincke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 8 | |
| 3 | 17 | |
| 4 | 6 | |
| 5 | 21 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 25 | |
| 9 | 12 | |
| 10 | 38 | |
| 11 | 33 | |
| 12 | 47 | |
| 13 | 20 | |
| 14 | 14 | |
| 15 | 42 | |
| 16 | 60 | |
| 17 | 14 | |
| 18 | 46 | |
| 19 | Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. | 141 |
| 20 | Antibodies to fentanyl. | 33 |
About James M. Frincke
James M. Frincke is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Genetics, having authored 73 papers that have together received 2.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Estrogen and related hormone effects (14 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Biological Psychiatry (47 citations) and Oncology (437 citations). James M. Frincke has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include D. John Faulkner, Gary S. David, Richard M. Bartholomew, Christopher L. Reading, Clarence Ahlem, Dwight R. Stickney, Phillip L. Hagan, Samuel E. Halpern, Dominick L. Auci and Armando Garsd. Their work appears in journals such as Nature, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.